Lftd Partners Inc. (LIFD): Capital Expenditures
$121.6K
Year ended 2025-12-31
$176.1K
Trailing 12 months to 2026-06-30
-49.0%
3-year compound annual growth
+11.6%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $121.6K | -61.2% | 2026-04-01, From 2025-01-01 |
| 2024-12-31 | $313.8K | -60.3% | 2026-04-01, From 2024-01-01 |
| 2023-12-31 | $789.7K | -13.8% | 2026-04-01, From 2023-01-01 |
| 2022-12-31 | $916.1K | +148.8% | 2025-03-31, From 2022-01-01 |
| 2021-12-31 | $368.2K | +425.0% | 2024-03-29, From 2021-01-01 |
| 2020-12-31 | $70.1K | n/a | 2023-03-21, From 2020-01-01 |
| 2019-12-31 | $0 | n/a | 2022-03-31, From 2019-01-01 |
| No annual figure between 2011-12-31 and 2019-12-31. | |||
| 2011-12-31 | -$23.4K | n/m | 2012-03-30, From 2011-01-01 |
| 2010-12-31 | -$42.9K | n/a | 2012-03-30, From 2010-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $121.6K | -61.2% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $174.5K | -89.5% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $1.57M | +552.4% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $756.6K | +0.5% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $0 | -100.0% |
| Bioharvest Sciences Inc. (BHST) | 2025-12-31 | $2.35M | -16.9% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $2.0K | -80.0% |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $567.0K | -89.1% |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | $718.0K | -23.5% |
Compare LIFD, SBFM, BGM, ETST side by side · Screen every company in Pharmaceutical Preparations ↗